These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 15528273

  • 21. Estrogen modulates cardiac growth through an estrogen receptor α-dependent mechanism in healthy ovariectomized mice.
    Kararigas G, Nguyen BT, Jarry H.
    Mol Cell Endocrinol; 2014 Feb 15; 382(2):909-14. PubMed ID: 24275180
    [Abstract] [Full Text] [Related]

  • 22. Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway.
    Kazi AA, Koos RD.
    Endocrinology; 2007 May 15; 148(5):2363-74. PubMed ID: 17272396
    [Abstract] [Full Text] [Related]

  • 23. Estrogen receptor alpha (ERalpha) and insulin-like growth factor I receptor (IGF-IR) cross-talk in the gonadotropic alphaT3-1 cell line.
    Eertmans F, Dhooge W, De Wever O, Bracke M, Comhaire F, Kaufman JM.
    J Cell Physiol; 2007 Sep 15; 212(3):583-90. PubMed ID: 17458895
    [Abstract] [Full Text] [Related]

  • 24. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
    Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA, Korach KS.
    Endocrinology; 1996 May 15; 137(5):1735-44. PubMed ID: 8612509
    [Abstract] [Full Text] [Related]

  • 25. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A, Bonofiglio D, Recchia AG, Musti AM, Picard D, Andò S, Maggiolini M.
    Mol Endocrinol; 2006 Mar 15; 20(3):631-46. PubMed ID: 16239258
    [Abstract] [Full Text] [Related]

  • 26. Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions.
    Adlanmerini M, Solinhac R, Abot A, Fabre A, Raymond-Letron I, Guihot AL, Boudou F, Sautier L, Vessières E, Kim SH, Lière P, Fontaine C, Krust A, Chambon P, Katzenellenbogen JA, Gourdy P, Shaul PW, Henrion D, Arnal JF, Lenfant F.
    Proc Natl Acad Sci U S A; 2014 Jan 14; 111(2):E283-90. PubMed ID: 24371309
    [Abstract] [Full Text] [Related]

  • 27. Gene regulation in an MCF-7 cell line that naturally expresses an estrogen receptor unable to directly bind DNA.
    Pentecost BT, Bradley LM, Gierthy JF, Ding Y, Fasco MJ.
    Mol Cell Endocrinol; 2005 Jun 30; 238(1-2):9-25. PubMed ID: 15913882
    [Abstract] [Full Text] [Related]

  • 28. Temporal analysis of E2 transcriptional induction of PTP and MKP and downregulation of IGF-I pathway key components in the mouse uterus.
    Ivanga M, Labrie Y, Calvo E, Belleau P, Martel C, Luu-The V, Morissette J, Labrie F, Durocher F.
    Physiol Genomics; 2007 Mar 14; 29(1):13-23. PubMed ID: 17361005
    [Abstract] [Full Text] [Related]

  • 29. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells.
    Klinge CM, Blankenship KA, Risinger KE, Bhatnagar S, Noisin EL, Sumanasekera WK, Zhao L, Brey DM, Keynton RS.
    J Biol Chem; 2005 Mar 04; 280(9):7460-8. PubMed ID: 15615701
    [Abstract] [Full Text] [Related]

  • 30. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells.
    Monroe DG, Secreto FJ, Subramaniam M, Getz BJ, Khosla S, Spelsberg TC.
    Mol Endocrinol; 2005 Jun 04; 19(6):1555-68. PubMed ID: 15802376
    [Abstract] [Full Text] [Related]

  • 31. Dexamethasone attenuates the estradiol-induced increase of IGF-I mRNA in the rat uterus.
    Sahlin L.
    J Steroid Biochem Mol Biol; 1995 Oct 04; 55(1):9-15. PubMed ID: 7577725
    [Abstract] [Full Text] [Related]

  • 32. Regulation of uterine hsp90alpha, hsp72 and HSF-1 transcription in B6C3F1 mice by beta-estradiol and bisphenol A: involvement of the estrogen receptor and protein kinase C.
    Papaconstantinou AD, Goering PL, Umbreit TH, Brown KM.
    Toxicol Lett; 2003 Sep 30; 144(2):257-70. PubMed ID: 12927369
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Impaired estrogen action in the uterus of insulin-like growth factor binding protein-1 transgenic mice.
    Rajkumar K, Dheen T, Krsek M, Murphy LJ.
    Endocrinology; 1996 Apr 30; 137(4):1258-64. PubMed ID: 8625897
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Distinctive actions of membrane-targeted versus nuclear localized estrogen receptors in breast cancer cells.
    Rai D, Frolova A, Frasor J, Carpenter AE, Katzenellenbogen BS.
    Mol Endocrinol; 2005 Jun 30; 19(6):1606-17. PubMed ID: 15831524
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. An estrogen receptor-alpha splicing variant mediates both positive and negative effects on gene transcription.
    Bollig A, Miksicek RJ.
    Mol Endocrinol; 2000 May 30; 14(5):634-49. PubMed ID: 10809228
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB.
    Oncogene; 2002 Jun 06; 21(25):4000-8. PubMed ID: 12037682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.